Delandistrogene moxeparvovec-rokl clinical trials

An Open-Label, Systemic Gene Delivery Study to Evaluate the Safety, Tolerability and Expression of SRP-9001 in Association with Imlifidase in Subjects with Duchenne Muscular Dystrophy with Pre-existing Antibodies to rAAVrh74

This study is looking at a new gene therapy for Duchenne muscular dystrophy in males who already have certain antibodies. It's testing if the treatment is safe, how well people tolerate it, and if the therapy's active ingredient can be produced in their muscles.